Pfizer announced a quarterly dividend on Thursday, September 22nd.

This puts Albert Bourla in the top 30% of approval ratings compared to other CEOs of publicly-traded companies. Pfizer announced a quarterly dividend on Thursday, September 22nd. Stockholders of record on Friday, November 4th will be paid a dividend of $0.40 per share on Monday, December 5th. This represents a $1.60 dividend nasdaq PFE on an annualized basis and a dividend yield of 3.36%. The ex-dividend date of this dividend is Thursday, November 3rd. In the past three months, Pfizer insiders have not sold or bought any company stock. MarketBeat has tracked 56 news articles for Pfizer this week, compared to 24 articles on an average week.

Pfizer stock

To put that into context, consider that the benchmark S&P 500 Index has increased by just 17% over the same period. Over the past three years, the company’s dividend has grown by an average of 4.39% per year. Sign Up NowGet this delivered to your inbox, and more info about our products and services. MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security. One share of PFE stock can currently be purchased for approximately $47.65. 358 employees have rated Pfizer Chief Executive Officer Albert Bourla on Albert Bourla has an approval rating of 92% among the company’s employees.

Pfizer Will Dominate Rsv Vaccine Market, Ceo Says

© 2022 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided ‘as-is’ and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see Barchart’s disclaimer.

Pfizer has received a 67.54% net impact score from Upright. The largest positive contribution comes from its “Physical diseases” impact, which is mostly driven by its “Covid-19 vaccines”, “Pneumococcal vaccines”, and “Apixaban” products. Pfizer Forex news pays a meaningful dividend of 3.39%, higher than the bottom 25% of all stocks that pay dividends. Pfizer has a short interest ratio (“days to cover”) of 3.2, which is generally considered an acceptable ratio of short interest to trading volume.

This indicates that Pfizer will be able to sustain or increase its dividend. UBS analyst Colin Bristow maintained a Buy rating on Pfizer (PFE – Research Report) today and set a price target of $55.00. The company’s shares opened today Pfizer stock price today at $46.36.According to TipRanks, Bristow is an analyst with an a… In a report released yesterday, Lorenzo Biasio from Credit Suisse maintained a Hold rating on Pfizer (PFE – Research Report), with a price target of $42.00.

Expert Ratings For Pfizer

(0.22%), The Manufacturers Life Insurance Company (0.21%), Nordea Investment Management AB (0.20%), Prudential Financial Inc. (0.18%) and DekaBank Deutsche Girozentrale (0.15%). Insiders that own company stock include Alexander R Mackenzie, Douglas M Lankler, Jennifer B Damico, John D Young, Pfizer Inc, Ronald E Blaylock, Scott Forex news Gottlieb and William R Carapezzi Jr. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 to -2 . This news sentiment score is similar to the average news sentiment of Medical companies. This payout ratio is at a healthy, sustainable level, below 75%.

  • Investopedia does not include all offers available in the marketplace.
  • One of the largest pharmaceutical companies in the world, Pfizer’s name recognition has increased more recently thanks to the introduction of its COVID-19 vaccine.
  • Specifically, according to consensus estimates, Pfizer should report earnings per share of $1.40 in Q3, a year-over-year increase of almost 5%.
  • The offers that appear in this table are from partnerships from which Investopedia receives compensation.
  • Eliquis , used to treat nonvalvular atrial fibrillation, deep vein thrombosis, and pulmonary embolism, with more than $1.3 billion in revenue from direct sales and alliance revenues.
  • Pfizer is a large company that has been around for decades.

Pfizer’s stock was trading at $59.05 at the beginning of the year. Since then, PFE shares have decreased by 19.3% and is now trading at $47.65. Based on earnings estimates, Pfizer will have a dividend payout ratio of 32.59% next year.

Price Target And Rating

Pfizer’s earnings and revenue for the third quarter of FY 2021, fueled by sales of its COVID-19 vaccine, surpassed analysts’ expectations. Inc. , Switzerland-based Roche Holding AG , and Eli Lilly and Co. . Pfizer reported adjusted net income attributable to its common shareholders of $25.2 dotbig billion on $81.3 billion in annual revenue in its 2021 fiscal year . Albert Bourla is the pharmaceutical giant’s current chief executive officer . The company traces its origins to the founding of Charles Pfizer & Co. in Brooklyn, N.Y., in 1849 by Charles Pfizer and Charles Erhart.

Pfizer Inc Stock Falls Thursday, Still Outperforms Market

“Pfizer is taking the savvy approach of redeploying this short-term [COVID-19] windfall into longer-lived biotechnology assets ,” he said. The most recent change in the company’s dividend was an increase of $0.01 on Friday, December 10, 2021. dotbig Pfizer’s most recent quarterly dividend payment of $0.40 per share was made to shareholders on Tuesday, September 6, 2022. Pfizer’s next quarterly dividend payment of $0.40 per share will be made to shareholders on Monday, December 5, 2022.

Insiders & Institutions

The healthcare sector consists of companies that provide medical services, manufacture medical equipment or drugs, provide medical insurance, or otherwise facilitate the provision of healthcare to patients. Albert Bourla, who has been with Pfizer for more than 25 years, is currently the company’s chief executive officer and chairman. Before assuming the CEO position in January 2019, PFE stock forecast he was chief operating officer starting in January 2018. From February 2016 to December 2018, Bourla was group president of Pfizer’s Global Vaccines, Oncology, and Consumer Healthcare business. He was president and general manager of the company’s Established Products business from 2010 to 2013. Bourla served in a number of other roles from 1993, when he joined the company, to 2010.

Control Of Congress Up For Grabs In Midterms: 12 Stocks To Watch

Like any other public company, Pfizer faces competition and market obstacles that could affect its future. After paying your bills, make sure you’re setting aside funds for retirement and your emergency fund. Then decide how much of the money you have left over after taking care of these three things to invest in stocks like Pfizer. If you want to invest to grow your money but don’t have a specific goal in mind and don’t want to worry about withdrawal penalties, another option is to open a taxable investment account. There aren’t any tax benefits, but you aren’t limited in how you use the money. Over the last 12 months, shares of Pfizer’s stock have gained approximately 47%.

On June 12, 2022, the FDA released an analysis stating that the Pfizer-BioNTech COVID-19 vaccine is safe and effective for children under the age of 5. Most brokerages offer multiple account options, and you should choose the one best tailored to your financial goals. If you don’t have a brokerage account yet, look for ones that have no trading fees and low investment minimums. Although Pfizer’s future post-pandemic is less certain, Clulow is optimistic.

Leave a Comment

Your email address will not be published. Required fields are marked *